A Critical Evaluation of the Cardiac Toxicity of Citalopram: Part 2
- 1 December 2011
- journal article
- Published by SLACK, Inc. in Journal of Psychosocial Nursing and Mental Health Services
- Vol. 49 (12), 13-16
- https://doi.org/10.3928/02793695-20111102-04
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- A Critical Evaluation of the Cardiac Toxicity of Citalopram: Part 1Journal of Psychosocial Nursing and Mental Health Services, 2011
- Cytochrome P450-Dependent Disposition of the Enantiomers of Citalopram and Its Metabolites: In Vivo Studies in Sprague-Dawley and Dark Agouti RatsChirality, 2011
- Cardiovascular Abnormalities in Patients with Major Depressive DisorderCNS Drugs, 2009
- Use of specific serotonin reuptake inhibitors (SSRIs) (Sertraline or Citalopram) in the treatment of depression reduces the cardiovascular risk in the elderly: Evidence from a Sicilian population >80 years recovered in the assisted sanitary residences (RSA)Archives of Gerontology and Geriatrics, 2009
- Depressive symptoms in the congenital long QT syndromeAnnals of Medicine, 2009
- The Crucial Role of the Therapeutic Window in Understanding the Clinical Relevance of the Poor Versus the Ultrarapid Metabolizer Phenotypes in Subjects Taking Drugs Metabolized by CYP2D6 or CYP2C19Journal of Clinical Psychopharmacology, 2007
- Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients With Coronary Artery DiseaseJAMA, 2007
- QT interval duration in apparently healthy men is associated with depression-related personality trait neuroticismJournal of Psychosomatic Research, 2006
- Routine Therapeutic Drug Monitoring in Patients Treated with 10-360 mg/day CitalopramTherapeutic Drug Monitoring, 2003
- Selecting the optimum therapeutic dose of serotonin reuptake inhibitorsInternational Clinical Psychopharmacology, 1995